Strange Tony,
Humana has reported minimal information about Kindred at Home's finances since it became the 100% owner of the company in August 2021. Today's Q1 earnings report had top line revenue of $726 million for KAH but not much more. Assuming steady business throughout the year KAH would come in under $3 billion in revenue, i.e. less than when it acquired the company in July 2018. Hospice has some seasonality so the number could come in over $3 billion.
Hospice had higher margins than Home Health when Humana closed last summer on the 40% it did not own. Another sale of the hospice division to financial rapscallions should enrich CEO David Causby yet again. He's on his __nth king's ransom?
Some may recall Causby's butchering of the Harden Healthcare integration (during the Gentiva days). He combined Kindred Hospice with Curo Healthcare by keeping the brand salad and putting larger hospices under Curo's crappy technology and miserly staffing models.
Anyone who remembers the torture TPG Capital, WCAS and Humana put our hospice through must be dreading Clayton, Dubilier and Rice.
There has been no word on David Causby's response to the Senate Finance Committee's request for information on private equity ownership of hospice companies.
I'd love to read a report before our hospice gets sold down the river yet again.
Anonymous
No comments:
Post a Comment